Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Temprian Therapeutics Logo
Temprian Therapeutics Growth Score
83
CB Rank
398489
Heat Score
82
Temprian Therapeutics is a developer of therapies intended for autoimmune disease.
Founded
obfuscation
PrivateSeed Chicago, Illinois, United States1-10 tempriantherapeutics.com/
Pharmaceutical
Therapeutics
Overview

Temprian Therapeutics
Growth Score
83
Heat Score
82

Growth Score83
-5 pts
in past quarter
Heat Score 82
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Temprian Therapeutics

CB Rank
398489
Temprian Therapeutics is a developer of therapies intended for autoimmune disease.
Founded
obfuscation
PrivateSeed Chicago, Illinois, United States1-10 tempriantherapeutics.com/
Pharmaceutical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Temprian Therapeutics Inc.,
Operating Status Active
Company Type For Profit
About the Company
Temprian Therapeutics is a developer of therapies intended for autoimmune disease. The company offers DNA-based treatment by injecting DNA coding for a modified heat shock protein to stop the autoimmune response at the outset, enabling consumers to get treatments for vitiligo disease.
Phone Number +1 513-374-1180
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

TT-01
A systemic treatment for vitiligo that uses a genetically modified DNA plasmid to block the autoimmune response against melanocytes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - Temprian Therapeutics Logo
Seed Round - Temprian Therapeutics
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jun 30, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$79.3KThis year, Temprian Therapeutics is projected to spend $79.3K on IT, according to Aberdeen.

Active Website Tech Count

3Temprian Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Temprian Therapeutics's headquarters? Temprian Therapeutics is located in Chicago, Illinois, United States.When was the last funding round for Temprian Therapeutics? Temprian Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Temprian Therapeutics's competitors? Alternatives and possible competitors to Temprian Therapeutics may include Eli Lilly, Pfizer, and  AbbVie.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|